Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cldn23 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CLDN23 mRNA] | CTD | PMID:31150632 | Cldn23 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Cldn23 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of CLDN23 mRNA | CTD | PMID:22206623 | Cldn23 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CLDN23 mRNA | CTD | PMID:30723492 | Cldn23 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cldn23 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CLDN23 mRNA | CTD | PMID:19770486 | Cldn23 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CLDN23 mRNA | CTD | PMID:32109520 | Cldn23 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cldn23 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CLDN23 mRNA | CTD | PMID:21570461 | Cldn23 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in increased expression of CLDN23 mRNA | CTD | PMID:32109520 | Cldn23 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of CLDN23 mRNA | CTD | PMID:21346803 | Cldn23 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Decitabine affects the expression of CLDN23 mRNA | CTD | PMID:23300844 | Cldn23 | Rat | 5-aza-2'-deoxycytidine | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | Decitabine inhibits the reaction [Smoke results in decreased expression of CLDN23 mRNA] | CTD | PMID:21095227 | Cldn23 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of CLDN23 mRNA | CTD | PMID:24780913 | Cldn23 | Rat | acrylamide | affects expression | EXP | | 6480464 | Acrylamide affects the expression of CLDN23 mRNA | CTD | PMID:28959563 | Cldn23 | Rat | acrylamide | decreases expression | ISO | Cldn23 (Mus musculus) | 6480464 | Acrylamide results in decreased expression of CLDN23 mRNA | CTD | PMID:35032568 | Cldn23 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CLDN23 mRNA | CTD | PMID:35163327 | Cldn23 | Rat | arsane | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CLDN23 more ... | CTD | PMID:32525701 | Cldn23 | Rat | arsenic atom | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CLDN23 more ... | CTD | PMID:32525701 | Cldn23 | Rat | benzo[a]pyrene | increases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CLDN23 mRNA | CTD | PMID:20106945|PMID:22316170 | Cldn23 | Rat | benzo[a]pyrene | affects methylation | ISO | CLDN23 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CLDN23 exon | CTD | PMID:27901495 | Cldn23 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Cldn23 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of CLDN23 mRNA | CTD | PMID:34319233 | Cldn23 | Rat | bisphenol A | decreases expression | ISO | Cldn23 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CLDN23 mRNA | CTD | PMID:26063408 | Cldn23 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CLDN23 mRNA | CTD | PMID:34947998 | Cldn23 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CLDN23 mRNA | CTD | PMID:30816183 | Cldn23 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CLDN23 mRNA | CTD | PMID:25181051 | Cldn23 | Rat | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of CLDN23 mRNA | CTD | PMID:19167457 | Cldn23 | Rat | caffeine | decreases phosphorylation | ISO | CLDN23 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of CLDN23 protein | CTD | PMID:35688186 | Cldn23 | Rat | CGP 52608 | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CLDN23 gene] | CTD | PMID:28238834 | Cldn23 | Rat | choline | multiple interactions | ISO | Cldn23 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Cldn23 | Rat | cisplatin | affects expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Cisplatin affects the expression of CLDN23 mRNA | CTD | PMID:23300844 | Cldn23 | Rat | copper(II) sulfate | decreases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CLDN23 mRNA | CTD | PMID:19549813 | Cldn23 | Rat | CU-O LINKAGE | decreases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of CLDN23 mRNA | CTD | PMID:22077320 | Cldn23 | Rat | Cuprizon | affects expression | EXP | | 6480464 | Cuprizone affects the expression of CLDN23 mRNA | CTD | PMID:26577399 | Cldn23 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of CLDN23 mRNA | CTD | PMID:27523638 | Cldn23 | Rat | dibutyl phthalate | increases expression | ISO | Cldn23 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of CLDN23 mRNA | CTD | PMID:21266533 | Cldn23 | Rat | dorsomorphin | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cldn23 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of CLDN23 mRNA | CTD | PMID:29391264 | Cldn23 | Rat | entinostat | increases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | entinostat results in increased expression of CLDN23 mRNA | CTD | PMID:26272509 | Cldn23 | Rat | entinostat | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cldn23 | Rat | folic acid | multiple interactions | ISO | Cldn23 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Cldn23 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CLDN23 mRNA | CTD | PMID:25539665|PMID:27387713 | Cldn23 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CLDN23 mRNA | CTD | PMID:33387578 | Cldn23 | Rat | hydrogen peroxide | affects expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of CLDN23 mRNA | CTD | PMID:20044591 | Cldn23 | Rat | iron dichloride | decreases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of CLDN23 mRNA | CTD | PMID:35984750 | Cldn23 | Rat | L-methionine | multiple interactions | ISO | Cldn23 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Cldn23 | Rat | lead diacetate | increases expression | ISO | Cldn23 (Mus musculus) | 6480464 | lead acetate results in increased expression of CLDN23 mRNA | CTD | PMID:22609695 | Cldn23 | Rat | lidocaine | increases expression | EXP | | 6480464 | Lidocaine results in increased expression of CLDN23 mRNA | CTD | PMID:35283115 | Cldn23 | Rat | manganese atom | increases expression | EXP | | 6480464 | Manganese results in increased expression of CLDN23 mRNA | CTD | PMID:26745496 | Cldn23 | Rat | manganese(0) | increases expression | EXP | | 6480464 | Manganese results in increased expression of CLDN23 mRNA | CTD | PMID:26745496 | Cldn23 | Rat | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of CLDN23 mRNA | CTD | PMID:26745496 | Cldn23 | Rat | menadione | affects expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of CLDN23 mRNA | CTD | PMID:20044591 | Cldn23 | Rat | methotrexate | increases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of CLDN23 mRNA | CTD | PMID:21678067 | Cldn23 | Rat | methylmercury chloride | increases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of CLDN23 mRNA | CTD | PMID:28001369 | Cldn23 | Rat | ochratoxin A | decreases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of CLDN23 mRNA | CTD | PMID:30763683 | Cldn23 | Rat | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of CLDN23 mRNA | CTD | PMID:23665939 | Cldn23 | Rat | panobinostat | increases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | panobinostat results in increased expression of CLDN23 mRNA | CTD | PMID:26272509 | Cldn23 | Rat | panobinostat | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cldn23 | Rat | paracetamol | increases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CLDN23 mRNA | CTD | PMID:21420995 | Cldn23 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CLDN23 mRNA | CTD | PMID:33387578 | Cldn23 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CLDN23 mRNA | CTD | PMID:35163327 | Cldn23 | Rat | phenylmercury acetate | increases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of CLDN23 mRNA | CTD | PMID:26272509 | Cldn23 | Rat | phenylmercury acetate | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Cldn23 | Rat | pirinixic acid | multiple interactions | ISO | Cldn23 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Cldn23 | Rat | progesterone | multiple interactions | ISO | Cldn23 (Mus musculus) | 6480464 | NCOA2 protein affects the reaction [Progesterone results in increased expression of CLDN23 mRNA] | CTD | PMID:17556502 | Cldn23 | Rat | progesterone | increases expression | ISO | Cldn23 (Mus musculus) | 6480464 | Progesterone results in increased expression of CLDN23 mRNA | CTD | PMID:17556502 | Cldn23 | Rat | quercitrin | affects expression | ISO | CLDN23 (Homo sapiens) | 6480464 | quercitrin affects the expression of CLDN23 mRNA | CTD | PMID:25193878 | Cldn23 | Rat | resveratrol | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of CLDN23 mRNA | CTD | PMID:23557933 | Cldn23 | Rat | SB 431542 | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Cldn23 | Rat | sodium arsenate | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CLDN23 more ... | CTD | PMID:32525701 | Cldn23 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CLDN23 mRNA | CTD | PMID:31150632 | Cldn23 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CLDN23 mRNA] | CTD | PMID:31150632 | Cldn23 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CLDN23 mRNA | CTD | PMID:23411599|PMID:34492290 | Cldn23 | Rat | titanium dioxide | decreases methylation | ISO | Cldn23 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CLDN23 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Cldn23 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of CLDN23 mRNA | CTD | PMID:33387578 | Cldn23 | Rat | trichostatin A | increases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CLDN23 mRNA | CTD | PMID:24935251|PMID:26272509 | Cldn23 | Rat | trichostatin A | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Cldn23 | Rat | valproic acid | increases methylation | ISO | CLDN23 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of CLDN23 gene | CTD | PMID:29154799 | Cldn23 | Rat | valproic acid | affects expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CLDN23 mRNA | CTD | PMID:25979313 | Cldn23 | Rat | valproic acid | increases expression | ISO | CLDN23 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CLDN23 mRNA | CTD | PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799 | Cldn23 | Rat | valproic acid | multiple interactions | ISO | CLDN23 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















